CERS2 and Alzheimer disease: Transcriptomic analysis of AD brains shows an upregulation of ceramide synthase 1 and 2 (CerS1 & CerS2), which are responsible for the addition of C18 only and C18, C20, and C22 acyl groups, respectively (Czubowicz et al.